These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Precocious puberty]. Buzi F; De Sanctis C; De Sanctis V; Radetti G; Rigon F; Tatò L; Tonini G; Bernasconi S; Bona G; Bozzola M Minerva Pediatr; 1996 Dec; 48(12):575-80. PubMed ID: 9091776 [No Abstract] [Full Text] [Related]
6. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty. Bajpai A; Sharma J; Kabra M; Gupta AK; Menon PS Indian Pediatr; 2002 Jul; 39(7):633-9. PubMed ID: 12147888 [TBL] [Abstract][Full Text] [Related]
7. Subcutaneous gonadotropin-releasing hormone agonist (triptorelin) test for diagnosing precocious puberty. Poomthavorn P; Khlairit P; Mahachoklertwattana P Horm Res; 2009; 72(2):114-9. PubMed ID: 19690429 [TBL] [Abstract][Full Text] [Related]
8. The histrelin implant: a novel treatment for central precocious puberty. Hirsch HJ; Gillis D; Strich D; Chertin B; Farkas A; Lindenberg T; Gelber H; Spitz IM Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137 [TBL] [Abstract][Full Text] [Related]
9. Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist. Yeshaya A; Kauschansky A; Orvieto R; Varsano I; Nussinovitch M; Ben-Rafael Z Acta Obstet Gynecol Scand; 1998 Mar; 77(3):327-9. PubMed ID: 9539281 [TBL] [Abstract][Full Text] [Related]
10. Central precocious puberty in a girl with Williams syndrome: the result of treatment with GnRH analogue. Utine GE; Alikasifoglu A; Alikasifoglu M; Tuncbilek E Eur J Med Genet; 2006; 49(1):79-82. PubMed ID: 16473313 [TBL] [Abstract][Full Text] [Related]
11. Sterile abscess formation associated with depot leuprorelin acetate therapy for central precocious puberty. Johnson SR; Nolan RC; Grant MT; Price GJ; Siafarikas A; Bint L; Choong CS J Paediatr Child Health; 2012 Mar; 48(3):E136-9. PubMed ID: 21564386 [TBL] [Abstract][Full Text] [Related]
13. Early puberty in boys with myelomeningocele. Dahl M; Proos LA; Ahlsten G; Tuvemo T; Gustafsson J Eur J Pediatr Surg; 1997 Dec; 7 Suppl 1():50. PubMed ID: 9497125 [No Abstract] [Full Text] [Related]
14. Treatment of central precocious puberty. Partsch CJ; Sippell WG Best Pract Res Clin Endocrinol Metab; 2002 Mar; 16(1):165-89. PubMed ID: 11987906 [TBL] [Abstract][Full Text] [Related]
15. Leuprolide acetate (Fensolvi) for central precocious puberty. Med Lett Drugs Ther; 2021 Sep; 63(1634):e1-e2. PubMed ID: 34606489 [No Abstract] [Full Text] [Related]
16. Editorial: does lupron dosage make a difference in outcome when treating children with precocious puberty? Foster CM J Clin Endocrinol Metab; 2006 May; 91(5):1667-8. PubMed ID: 16679509 [No Abstract] [Full Text] [Related]
17. Leptin changes in Taiwanese girls with central precocious puberty before and during the GnRH agonist treatment. Su PH; Wang SL; Lin CY; Chen JY; Changlai CP; Jian SH; Chen SJ Acta Paediatr Taiwan; 2005; 46(5):278-83. PubMed ID: 16640001 [TBL] [Abstract][Full Text] [Related]
18. Precocious puberty and statural growth. Carel JC; Lahlou N; Roger M; Chaussain JL Hum Reprod Update; 2004; 10(2):135-47. PubMed ID: 15073143 [TBL] [Abstract][Full Text] [Related]
19. Treatment of central precocious puberty by GnRH analogs: long-term outcome in men. Bertelloni S; Mul D Asian J Androl; 2008 Jul; 10(4):525-34. PubMed ID: 18478155 [TBL] [Abstract][Full Text] [Related]